Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Updated on: January 23,2024

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Updated on:January 23,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on: February 01,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on:February 01,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on: January 29,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on:January 29,2024

New study brings personalized immunotherapy prescriptions a step closer

byUniversity of BathCredit: Unsplash/CC0 Public DomainIn a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers ar

Updated on: January 13,2024

New study brings personalized immunotherapy prescriptions a step closer

byUniversity of BathCredit: Unsplash/CC0 Public DomainIn a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers ar

Updated on:January 13,2024

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on: January 11,2024

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on:January 11,2024

Experts call for a targeted approach to cancer prevention

by University of StirlingCredit: CC0 Public DomainPolicymakers around the world should consider introducing more targeted early interventions in a bid to tackle cancer, according to experts at th

Updated on: April 07,2024

Experts call for a targeted approach to cancer prevention

by University of StirlingCredit: CC0 Public DomainPolicymakers around the world should consider introducing more targeted early interventions in a bid to tackle cancer, according to experts at th

Updated on:April 07,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on: April 07,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on:April 07,2024

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Updated on: March 01,2024

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Updated on:March 01,2024

A chemistry pioneer works to improve a flawed test for a common cancer

by Clare Milliken,Northwestern UniversityKelleher says top-down proteomics provides a more comprehensiveunderstanding of human proteins than bottom-up proteomics, which is both imprecise a

Updated on: May 23,2024

A chemistry pioneer works to improve a flawed test for a common cancer

by Clare Milliken,Northwestern UniversityKelleher says top-down proteomics provides a more comprehensiveunderstanding of human proteins than bottom-up proteomics, which is both imprecise a

Updated on:May 23,2024

Major breakthrough in quest for cancer vaccine

by University of MontrealCredit: CC0 Public DomainThe idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove ex

Updated on: March 06,2024

Major breakthrough in quest for cancer vaccine

by University of MontrealCredit: CC0 Public DomainThe idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove ex

Updated on:March 06,2024

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud

Updated on: March 14,2024

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud

Updated on:March 14,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on: January 02,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on:January 02,2024